首页 | 本学科首页   官方微博 | 高级检索  
     

西松烷型二萜衍生物的合成及抗肿瘤活性研究
引用本文:罗俊,尚海,成伟华,李凌宇,张宏武,马林,邹忠梅. 西松烷型二萜衍生物的合成及抗肿瘤活性研究[J]. 中草药, 2017, 48(3): 460-467
作者姓名:罗俊  尚海  成伟华  李凌宇  张宏武  马林  邹忠梅
作者单位:西南科技大学生命科学与工程学院, 四川 绵阳 621010;中国医学科学院北京协和医学院药用植物研究所, 北京 100193;中国医学科学院北京协和医学院药用植物研究所, 北京 100193;中国医学科学院北京协和医学院药用植物研究所, 北京 100193;中国医学科学院北京协和医学院药用植物研究所, 北京 100193;中国医学科学院北京协和医学院药用植物研究所, 北京 100193;西南科技大学生命科学与工程学院, 四川 绵阳 621010;中国医学科学院北京协和医学院药用植物研究所, 北京 100193
基金项目:北京市自然科学基金资助项目(7142111);国家自然科学基金资助项目(81502929)
摘    要:目的基于西松烷型二萜天然产物新巴豆瑞士松酸进行结构修饰,并对得到的衍生物进行体外抗肿瘤活性评价。方法以新巴豆瑞士松酸为起始原料,通过缩合反应、点击化学反应得到目标化合物。采用噻唑蓝(MTT)法考察所合成的目标化合物对HeLa、K562和K562A/02肿瘤细胞的抗增殖活性。结果合成了11个文献未报道的新巴豆瑞士松酸衍生物,其结构经~1H-NMR、~(13)C-NMR及HR-MS确定。活性测试结果表明,部分衍生物表现出一定的抗肿瘤活性,其中,化合物2f对HeLa细胞表现出良好活性,化合物2e对K562和耐药的K562A/02细胞表现出良好活性。结论部分衍生物对耐药的K562A/02细胞表现出抗肿瘤活性,具有进一步研究价值。

关 键 词:西松烷型二萜  新巴豆瑞士松酸  结构修饰  衍生物  抗肿瘤活性
收稿时间:2016-09-07

Synthesis and evaluation of cembranoid type diterpene derivatives as potential antitumor agents
LUO Jun,SHANG Hai,CHENG Wei-hu,LI Ling-yu,ZHANG Hong-wu,MA Lin and ZOU Zhong-mei. Synthesis and evaluation of cembranoid type diterpene derivatives as potential antitumor agents[J]. Chinese Traditional and Herbal Drugs, 2017, 48(3): 460-467
Authors:LUO Jun  SHANG Hai  CHENG Wei-hu  LI Ling-yu  ZHANG Hong-wu  MA Lin  ZOU Zhong-mei
Affiliation:Southwest University of Science and Technology, School of Life Science and Engineering, Mianyang 621010, China;Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100193, China;Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100193, China;Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100193, China;Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100193, China;Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100193, China;Southwest University of Science and Technology, School of Life Science and Engineering, Mianyang 621010, China;Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100193, China
Abstract:Objective To modify the structure of neocrotocembraneic acid, a cembranoid type diterpene, and evaluate the antitumor activities of the derivatives. Methods Taking neocrotocembraneic acid as starting material, the target compounds were synthesized by condensation reaction and click reaction. Their antitumor activities in vitro on HeLa, K562, and K562A/02 were evaluated by MTT. Results Eleven novel derivatives were synthesized which have not been reported in any literature and the structures were characterized by 1H-NMR,13C-NMR, and ESI-MS. MTT assay showed that some cembrane derivatives exhibited antitumor activities. In particular, compound 2f showed good antitumor activity against HeLa and compound 2e showed promising antitumor activity against K562 and K562A/02. Conclusion Some derivatives have demonstrated promising antitumor activities against K562/A02 cell lines which are worth further studying.
Keywords:cembranoid type diterpene  neocrotocembraneic acid  structural modification  derivative  antitumor activity
本文献已被 CNKI 等数据库收录!
点击此处可从《中草药》浏览原始摘要信息
点击此处可从《中草药》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号